Seguir
SABLONNIERE Bernard
SABLONNIERE Bernard
Professeur de Biochimie, Universite de Lille
Dirección de correo verificada de inserm.fr
Título
Citado por
Citado por
Año
Targeting chelatable iron as a therapeutic modality in Parkinson's disease
D Devos, C Moreau, JC Devedjian, J Kluza, M Petrault, C Laloux, ...
Antioxidants & redox signaling 21 (2), 195-210, 2014
4822014
Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1
N Sergeant, B Sablonnière, S Schraen-Maschke, A Ghestem, ...
Human molecular genetics 10 (19), 2143-2155, 2001
3182001
Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy
Y Gérard, L Maulin, Y Yazdanpanah, X De La Tribonnière, C Amiel, ...
Aids 14 (17), 2723-2730, 2000
2532000
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
2312017
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo …
C Moreau, A Delval, L Defebvre, K Dujardin, A Duhamel, G Petyt, ...
The lancet neurology 11 (7), 589-596, 2012
1932012
Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease
P Nazé, I Vuillaume, A Destée, F Pasquier, B Sablonnière
Neuroscience letters 328 (1), 1-4, 2002
1202002
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
J Dumurgier, S Schraen, A Gabelle, O Vercruysse, S Bombois, ...
Alzheimer's research & therapy 7 (1), 1-9, 2015
1052015
Clinical features and genetic analysis of a new form of spinocerebellar ataxia
D Devos, S Schraen–Maschke, I Vuillaume, K Dujardin, P Naze, ...
Neurology 56 (2), 234-238, 2001
1022001
A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21. 3‐p15. 1
I Vuillaume, D Devos, S Schraen‐Maschke, C Dina, A Lemainque, ...
Annals of Neurology: Official Journal of the American Neurological …, 2002
982002
Tau as a biomarker of neurodegenerative diseases
S Schraen-Maschke, N Sergeant, CM Dhaenens, S Bombois, ...
Future Medicine Ltd 2 (4), 363-384, 2008
962008
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
CM Dhaenens, S Burnouf, C Simonin, E Van Brussel, A Duhamel, ...
Neurobiology of disease 35 (3), 474-476, 2009
822009
Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
G Grolez, C Moreau, B Sablonnière, G Garçon, JC Devedjian, S Meguig, ...
BMC neurology 15 (1), 1-6, 2015
782015
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis
S Lehmann, S Schraen, I Quadrio, C Paquet, S Bombois, C Delaby, ...
Alzheimer's & Dementia 10, S390-S394. e2, 2014
782014
New syndromic form of benign hereditary chorea is associated with a deletion of TITF‐1 and PAX‐9 contiguous genes
D Devos, I Vuillaume, A De Becdelievre, B De Martinville, CM Dhaenens, ...
Movement disorders: official journal of the Movement Disorder Society 21 (12 …, 2006
752006
Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms
H Tran, N Gourrier, C Lemercier-Neuillet, CM Dhaenens, A Vautrin, ...
Journal of Biological Chemistry 286 (18), 16435-16446, 2011
732011
ETR‐3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I
O Leroy, CM Dhaenens, S Schraen‐Maschke, K Belarbi, A Delacourte, ...
Journal of neuroscience research 84 (4), 852-859, 2006
712006
TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment
J Delplanque, D Devos, V Huin, A Genet, O Sand, C Moreau, C Goizet, ...
Brain 137 (10), 2657-2663, 2014
662014
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats
CM Dhaenens, S Schraen-Maschke, H Tran, V Vingtdeux, D Ghanem, ...
Experimental neurology 210 (2), 467-478, 2008
652008
Association between caffeine intake and age at onset in Huntington's disease
C Simonin, C Duru, J Salleron, P Hincker, P Charles, A Delval, K Youssov, ...
Neurobiology of disease 58, 179-182, 2013
642013
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
C Moreau, A Delval, V Tiffreau, L Defebvre, K Dujardin, A Duhamel, ...
Journal of Neurology, Neurosurgery & Psychiatry 84 (5), 552-555, 2013
642013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20